Beyond classic unfavorable prognostic factors in endometrial cancer, such as tumor type II, higher grade and more advanced stage, higher Ki67 labeling, expression of the PTEN, p16, Notch2 and Notch3 proteins, as well as MMR proficiency were associated with increased relapse and mortality risk. This evidence concerns the gene MRC1 and endometrial cancer.